- Global Pharma News & Resources

Growth in chronic disease incidence worldwide will boost the critical care drugs market, forecast to grow at a CAGR of 10%

Noida, Uttar Pradesh, India, February 24 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Global Critical care drugs Market is estimated to see healthy growth, pegged at a CAGR of ~10% during the forecast period 2020-2025. Critical care drugs are the drugs primarily used in an emergency, which help treat significant illness and injuries. They are also used in specific care units such as coronary care unit (CCU), intensive care unit (ICU), or any other particular healthcare or trauma center. It is further incorporate to treat significant complications, or they are majorly used during surgeries.  There are various life-saving drugs such as calcium gluconate, adrenaline, Sodium bicarbonate, and others included in the critical care drugs.

Request Sample Report at:

Commonly used critical drugs are opioids, sedatives, and benzodiazepines. It can be used for various indications such as Cardiac arrest, chest pain, and injuries. The well-establishing healthcare infrastructure can be an essential factor, which can fuel the critical care drugs market.

An increasing chronic disease prevalence such as brain disorders and cardiovascular disease is the primary factor driving the critical care drugs market. The rising number of road accidents, leading to increased injuries, is expected to increase critical care drugs usage. Also, the growth in the number of surgeries worldwide can increase the scope for critical care drugs market development in the coming years. Other factors such as the presence of many hospitals, changing lifestyle of the people, intake of poor diet can cause chronic disorders, which can fuel the critical care drugs market.

Growing Number of ICU Beds in Countries with High COVID-19 cases

COVID-19 was declared a global pandemic by the World Health Organization on March 11, 2020. This novel disease is characterized by a lower number of initial cases followed by an infection explosion in various countries. Despite the implementation of lockdowns to reduce the spread of COVID-19, the healthcare systems in multiple countries have been overwhelmed by the demand for equipment, such as ICU beds and supportive equipment to treat severe disease cases.

Sector Overview

The sector has been segmented into Benzodiazepines, opioids, Sedatives, and Anesthetics. Apart from these drugs, many other critical care drugs are used to treat chronic disorders and many complicated injuries. These critical care drugs are life-saving drugs. The critical care drugs are generally used in operation theatres and intensive care units. Other critical care drugs include Nitroglycerine, Amlodipine, captopril, Succinyl Choline, and others. The most commonly used critical care drugs are opioids and are expected to hold a considerable revenue share in the overall critical care drugs market. Based on the end user, operation theatres and intensive care units are expected to have a large revenue share in the critical care drugs market.

Segmentation Overview of the Global Critical care drugs Market

The critical care drugs market has been segmented into Drug Type and End User. These major market segments are further categorized into various sub-segments to study the market in detail.

By Drug Type Outlook

Opoids (Morphine, Pethidine, Naloxone, Fentanyl) 
Benzodiazepines (Diazepam, Midazolam, Lorazepum, Flumazenil)

By End User Outlook (Intensive care unit (ICU), Coronary Care Unit (CCU), Operation Theatres, Trauma Centers)

Key Players Insights

Pfizer Inc, Cadila Pharmaceutica, Abbott, Triveni chemicals, Neon Laboratories Limited, Haffkine Bio-Pharmaceutical Corporation Ltd, and Cambrex Corporation, among others, are some significant players included in the research study of the global critical care drugs market.

For Purchase Enquiry:

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 24-Feb-2021